Red cells in post-genomic era: impact of personalized medicine in the treatment of anemias.
about
The European Hematology Association Roadmap for European Hematology Research: a consensus documentIsocitrate dehydrogenase mutations in myeloid malignancies.Diagnosis and management of congenital dyserythropoietic anemias.An enhancer haplotype may influence BCL11A expression levels and the response to hydroxyurea in β-thalassemia patients.
P2860
Red cells in post-genomic era: impact of personalized medicine in the treatment of anemias.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Red cells in post-genomic era: ...... e in the treatment of anemias.
@en
Red cells in post-genomic era: ...... e in the treatment of anemias.
@nl
type
label
Red cells in post-genomic era: ...... e in the treatment of anemias.
@en
Red cells in post-genomic era: ...... e in the treatment of anemias.
@nl
prefLabel
Red cells in post-genomic era: ...... e in the treatment of anemias.
@en
Red cells in post-genomic era: ...... e in the treatment of anemias.
@nl
P2860
P1433
P1476
Red cells in post-genomic era: ...... e in the treatment of anemias.
@en
P2093
Achille Iolascon
P2860
P356
10.3324/HAEMATOL.2014.120733
P577
2015-01-01T00:00:00Z